CSIMarket



Mylan N v   (MYL)
Other Ticker:  
 
 

MYL's Revenue Growth by Quarter and Year

Mylan N V 's Revenue results by quarter and year




MYL Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 8,538.80 3,078.70 3,144.00
III Quarter September 2,972.10 2,961.70 2,862.40 2,987.10
II Quarter June 2,731.20 - 2,808.30 2,719.50
I Quarter March 2,619.20 - 2,684.50 3,267.80
FY   8,322.50 11,500.50 11,433.90 12,118.40



MYL Revenue third quarter 2020 Y/Y Growth Comment
Mylan N v reported Revenue growth of 0.35% year on year in the third quarter 2020, to $ 2,972.10 millions, this is lower than Mylan N V 's recent average Revenue growth of 5.84%.

Looking into third quarter 2020 results within Major Pharmaceutical Preparations industry 108 other companies have achieved higher Revenue growth. While Mylan N V ' s Revenue increase of 0.35% ranks overall at the positon no. 1943 in the third quarter 2020.




MYL Revenue ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - 177.35 % -2.08 % 2.84 %
III Quarter September 0.35 % 3.47 % -4.17 % 16.65 %
II Quarter June - - 3.27 % 24.1 %
I Quarter March - - -17.85 % 31.2 %
FY   - 0.58 % -5.65 % 17.66 %

Financial Statements
Mylan N V 's third quarter 2020 Revenue $ 2,972.10 millions MYL's Income Statement
Mylan N V 's third quarter 2019 Revenue $ 2,961.70 millions Quarterly MYL's Income Statement
New: More MYL's historic Revenue Growth >>


MYL Revenue (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - 188.31 % 7.56 % 5.25 %
III Quarter September 8.82 % - 1.93 % 9.84 %
II Quarter June 4.28 % - 4.61 % -16.78 %
I Quarter March -69.33 % - -14.62 % 6.89 %
FY (Year on Year)   - 0.58 % -5.65 % 17.66 %




Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #109
Healthcare Sector #343
Overall #1943

Revenue Y/Y Growth Statistics
High Average Low
76.01 % 5.84 % -7.36 %
(Dec. 30, 2013)   (Sep. 30, 2009)
Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #109
Healthcare Sector #343
Overall #1943
Revenue Y/Y Growth Statistics
High Average Low
76.01 % 5.84 % -7.36 %
(Dec. 30, 2013)   (Sep. 30, 2009)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mylan N V 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
188.31 % 5.18 % -100 %
(Dec 31 2019)   (Mar 31 2019)


MYL's III. Quarter Q/Q Revenue Comment
Mylan N v achieved in the III. Quarter 2020 above company average sequential Revenue increase of 8.82%, to $ 2,972.10 millions, from $2,731.20 millions in the second quarter.
Mylan N V is going from strength to strength, with reporting better then normal growth, and additionally increasing pace, Angélica Almeida, market consultant said.

Within Major Pharmaceutical Preparations industry 96 other companies have achieved higher Revenue quarter on quarter growth. While Mylan N V 's Revenue growth quarter on quarter, overall rank is 2106.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #97
Healthcare Sector #374
Overall #2106
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #97
Healthcare Sector #374
Overall #2106
Revenue Q/Q Growth Statistics
High Average Low
188.31 % 5.18 % -100 %
(Dec 31 2019)   (Mar 31 2019)


MYL's III. Quarter Q/Q Revenue Comment
Mylan N v achieved in the III. Quarter 2020 above company average sequential Revenue increase of 8.82%, to $ 2,972.10 millions, from $2,731.20 millions in the second quarter.
Major Pharmaceutical Preparations company is undergoing a remarkable growth, not just claiming higher then regular growth, and additionally increasing rate, Angélica Almeida, market consultant added.

Within Major Pharmaceutical Preparations industry 96 other companies have achieved higher Revenue quarter on quarter growth. While Mylan N V 's Revenue growth quarter on quarter, overall rank is 2106.


Mylan N V 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Revenue 12 Months Ending $ 16,861.30 $ 16,850.90 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) 0.06 % - - - -
Seq. Revenue Growth (TTM) Overall Ranking # 1944 # 1945 # 0 # 0 # 0




Cumulative Revenue growth Comment
Although Mylan N V 's Annual Revenue growth year on year were below company's average 20.04% , Revenue announced in the Sep 30 2020 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 0.35% year on year, from % in Jun 30 2020. And, Mylan N V had the highest Revenue growth, in Major Pharmaceutical Preparations industry.

Mylan N v achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
76.01 %
5.84 %
-7.36 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
166.14 %
20.04 %
-34.88 %
(Sep. 30, 2008)   (Mar 31 2019)


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 109
Sector # 343
S&P 500 # 1944
Cumulative Revenue growth Comment
Although Mylan N V 's Annual Revenue growth year on year were below company's average 20.04% , Revenue announced in the Sep 30 2020 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 0.35% year on year, from % in Jun 30 2020. And, Mylan N V had the highest Revenue growth, in Major Pharmaceutical Preparations industry.

Mylan N v achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
76.01 %
5.84 %
-7.36 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
166.14 %
20.04 %
-34.88 %
(Sep. 30, 2008)   (Mar 31 2019)


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 109
Sector # 343
S&P 500 # 1944




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MYL's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for MYL's Competitors
Revenue Growth for Mylan N V 's Suppliers
Revenue Growth for MYL's Customers

You may also want to know
MYL's Annual Growth Rates MYL's Profitability Ratios MYL's Asset Turnover Ratio MYL's Dividend Growth
MYL's Roe MYL's Valuation Ratios MYL's Financial Strength Ratios MYL's Dividend Payout Ratio
MYL's Roa MYL's Inventory Turnover Ratio MYL's Growth Rates MYL's Dividend Comparisons



Companies with similar Revenue increase for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2020
Iqvia Holdings Inc 0.61%$ 0.614 millions
U s Neurosurgical Holdings Inc 0.61%$ 0.608 millions
Veracyte Inc 0.48%$ 0.478 millions
Lhc Group Inc0.41%$ 0.413 millions
Merit Medical Systems Inc0.38%$ 0.381 millions
Mylan N v 0.35%$ 0.351 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DBI's Profile

Stock Price

DBI's Financials

Business Description

Fundamentals

Charts & Quotes

DBI's News

Suppliers

DBI's Competitors

Customers & Markets

Economic Indicators

DBI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071